Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019

Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the trea...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Anna Maisa (Awdur), Christian Kollan (Awdur), Matthias an der Heiden (Awdur), Florian van Bömmel (Awdur), Markus Cornberg (Awdur), Stefan Mauss (Awdur), Heiner Wedemeyer (Awdur), Daniel Schmidt (Awdur), Sandra Dudareva (Awdur)
Fformat: Llyfr
Cyhoeddwyd: Frontiers Media S.A., 2021-05-01T00:00:00Z.
Pynciau:
Mynediad Ar-lein:Connect to this object online.
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Rhyngrwyd

Connect to this object online.

3rd Floor Main Library

Manylion daliadau o 3rd Floor Main Library
Rhif Galw: A1234.567
Copi 1 Ar gael